10-QHealthcare

Orthofix Medical Inc.

OFIX · Period ending 2026-09-30 · Filed 2026-11-09 · Updated

In short

Orthofix Medical Inc. (OFIX) has net income up 26.8% to -$92.2M and EPS (Diluted) up 29.4% to $-2.33 year on year. Its net margin is -11.2% and gross margin 68.8%. Fisclear flags 1 high-severity risk, led by: Net loss of $92.2M — the company spent more than it earned. Investors should monitor the path to profitability. How we calculate this

Valuation

Healthcare
Live · Yahoo Finance

Price

$6.07

P/B

0.6x

Price ÷ book value

P/S (TTM)

0.3x

Price ÷ revenue per share

Beta

0.64

Moderate market correlation

PEG Ratio

48.8x

P/E ÷ earnings growth rate

52-Week Range

$6.04$6.07 now$16.42

Decision Context

Altman Z-Score indicates financial distress risk. Review debt levels and cash runway before any position sizing decision.

Based on filing period ending Sept 2026

FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.

OFIX vs

Macro Context

Fed Funds Rate

3.88%

Accommodative

10-Year Treasury

5.13%

2026-10-01

Unemployment

4.1%

Near full employment

CPI Index

336.3

2026-09-01

M2 Money Supply

$23.4T

2026-09-01

The Federal Funds rate stands at 3.88% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 5.13%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.1%; Industrial production index is at 104.0; M2 money supply is $23.4T; CPI index stands at 336.3.

SWOT Analysis — OFIX

Inflationary Boom
Macro lens (Inflationary Boom): Rising costs and tighter margins amplify financial risks in this regime.
✦

Strengths

  • EPS (Diluted): $-2.33 (+29.4% YoY) — Negative EPS — the company recorded a loss on a per-share basis.

  • Operating Cash Flow: $33.3M (+29.3% YoY) — Operating cash flow grew 29% — the business generated more cash from day-to-day operations.

  • Net Income: -$92.2M (+26.8% YoY) — The company posted a net loss — total expenses exceeded total revenue.

◈

Weaknesses

  • Total Assets: $850.6M (-4.8% YoY) — Total assets shrank 5% — the balance sheet contracted.

  • Price-to-book ratio of 0.70x — stock trades below book value, which may indicate market concerns about asset quality or profitability.

◎

Opportunities

  • Gross Profit: $566.0M (+3.7% YoY) — Gross profit rose 4% — the spread between revenue and direct costs improved.

⚠

Threats

  • Net loss of $92.2M — the company spent more than it earned. Investors should monitor the path to profitability.

Year-over-Year Changes

EPS (Diluted)

$-2.33

was $-3.30

+29.4%

Negative EPS — the company recorded a loss on a per-share basis.

Operating Cash Flow

$33.3M

was $25.8M

+29.3%

Operating cash flow grew 29% — the business generated more cash from day-to-day operations.

Net Income

-$92.2M

was -$126.0M

+26.8%

The company posted a net loss — total expenses exceeded total revenue.

Total Assets

$850.6M

was $893.3M

−4.8%

Total assets shrank 5% — the balance sheet contracted.

Gross Profit

$566.0M

was $545.9M

+3.7%

Gross profit rose 4% — the spread between revenue and direct costs improved.

Risk Flags

1 high · 0 medium · 1 low
  • ⚠ High

    Net loss of $92.2M — the company spent more than it earned. Investors should monitor the path to profitability.

  • ○ Low

    Price-to-book ratio of 0.70x — stock trades below book value, which may indicate market concerns about asset quality or profitability.

Technical Signals

Daily closes · 1-year data

Orthofix Medical Inc.: common questions

Is Orthofix Medical Inc. profitable?

No. Orthofix Medical Inc. reported a net loss of $92M in its latest fiscal year (fiscal 2025), a net margin of -11.2%.

What is Orthofix Medical Inc.'s P/E ratio?

Orthofix Medical Inc. has no meaningful P/E ratio at the moment, because it lost money over the latest year. P/E only works when earnings are positive.

Does Orthofix Medical Inc. pay a dividend?

No dividend is currently expected from Orthofix Medical Inc., according to the latest market data.

What are the main risks for Orthofix Medical Inc.?

Fisclear's checks flag 1 medium- or high-severity risk. The most serious: Net loss of $92.2M — the company spent more than it earned. Investors should monitor the path to profitability.

Answers are generated from the figures in this report (updated 10 Nov 2026). Information, not investment advice.

Latest News

via Finnhub

Filing History — OFIX

Get the weekly digest

5 company reports + macro context every week, free. No spam.

  • Unlimited goal simulations
  • 5 free company report summaries per day
  • Weekly financial insights newsletter

External Links

Trade OFIX

Links open broker research pages. Not an endorsement or recommendation.

Research Orthofix Medical Inc.

Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.